Bistability in autoimmune diseases

Autoimmunity

Volumn 44, Issue 4, 2011, Pages 256-260

  Rapin, Nicolas ^a   Mosekilde, Erik ^b   Lund, Ole ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Autoimmunity; bistability; mathematical modeling

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DEATH; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MATHEMATICAL MODEL; STEADY STATE; TARGET CELL;

AUTOIMMUNE DISEASES; HOMEOSTASIS; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 79954567841     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2010.523233     Document Type: Article

References (19)

1. Ermann J, Fathman CG. Autoimmune diseases: Genes, bugs and failed regulation. Nat Immunol 2001;2(9): 759-761.
2. Noorchashm H, Greeley SAW, Naji A. B-cell deficiency and type 1 diabetes. N Engl J Med 2002;346(7):538-539.
3. Lisman JE. A mechanism for memory storage insensitive to molecular turnover: A bistable autophosphorylating kinase. Proc Natl Acad Sci USA 1985;82(9):3055-3057. (Pubitemid 15097791)
4. Perelson AS. Modelling viral and immune system dynamics. Nat Rev Immunol 2002;2(1):28-36. (Pubitemid 37328773)
5. Wodarz D, Jansen VAA. A dynamical perspective of CTL cross-priming and regulation: Implications for cancer immunology. Immunol Lett 2003;86(3):213-227. (Pubitemid 36428681)
6. Borghans JA, De Boer RJ, Sercarz E, Kumar V. T cell vaccination in experimental autoimmune encephalomyelitis: A mathematical model. J Immunol 1998;161(3): 1087-1093. (Pubitemid 28380532)
7. Iwami S, Takeuchi Y, Miura Y, Sasaki T, Kajiwara T. Dynamical properties of autoimmune disease models: Tolerance, flare-up, dormancy. J Theor Biol 2007;246(4): 646-659. (Pubitemid 46719258)
8. + T-cell vaccination against simian/human immunodeficiency virus. J Virol 2007;81(6):2838-2848. (Pubitemid 46447047)
9. Borghans JA, de Boer RJ, Segel LA. Extending the quasisteady state approximation by changing variables. Bull Math Biol 1996;58(1):43-63. (Pubitemid 126690448)
10. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1- receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356(15):1517-1526. (Pubitemid 46588416)
11. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin J, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M,Waldmann H, Bach J-F, Pipeleers D, Chatenoud L. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352(25):2598-2608. (Pubitemid 41007846)
12. Thye T, Scarisbrick G, Browne ENL, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Niemann S, Rüsch-Gerdes S, Meyer CG, Horstmann RD. CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an african population. PLoS One 2009;4(7):e6307.
13. Jonker M, Bakker K, Slierendregt B, Hart BT, Bontrop R. Autoimmunity in non-human primates: The role of major histocompatibility complex and T cells, and implications for therapy. Human Immunol 1991;32(1):31-40.
14. Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65- 79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Human Immunol 1999;60(7):575-582. (Pubitemid 29328612)
15. Faustman DL. MHC class I and autoimmune diabetes. Biomed Pharmacother 1993;47(1):3-10. (Pubitemid 23074089)
16. Cheong KY, Allcock RJN, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Human Immunol 2001;62(12):1363-1370. (Pubitemid 33116974)
17. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, Symmons DPM, Venables PJ, Klareskog L, Lundberg K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009;41(12):1319-1324.
18. Vial T, Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 1995;105(1):31-57. (Pubitemid 26018107)
19. Mellergård J, Havarinasab S, Hultman P. Short- and long-term effects of T-cell modulating agents in experimental autoimmunity. Toxicology 2004;196(3):197-209. (Pubitemid 38221494)